Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a significant burden globally, particularly in the Arabian Gulf region. The United Arab Emirates (UAE) has experienced rising MRSA prevalence, with increasing diversity in the clonal complexes (CCs) identified. The COVID-19 pandemic, with its increased hospitalization rates and antibiotic use, may have further influenced MRSA’s genetic evolution and epidemiology in the country. Methods: To investigate this influence, genomic profiling of 310 MRSA clinical isolates collected between February and November 2022 was performed using a DNA microarray-based assay. Results: Isolates were assigned to 22 clonal complexes and 72 distinct strain assignments. The predominant clonal complexes were CC5, CC6, CC361, CC22, CC1, and CC8. Community-acquired MRSA lineages were dominant, with only one healthcare-associated MRSA lineage isolate identified. Upward trends of CC1153 were observed along with rare CCs, such as CC121-MRSA and CC7-MRSA, with the latter being reported for the first time in the Arabian Gulf region. The presence of pandemic strains USA300 CC8-MRSA-[IVa + ACME1] and CC8-MRSA-IV strains were also observed, including variants lacking Panton–Valentine leukocidin (pvl) genes and missing tst1 or enterotoxin genes. The PVL-negative CC772-MRSA-V/VT was identified, representing its first report in the UAE. A novel variant, CC361-MRSA-IV (tst1+/PVL+), was identified. Pvl genes were observed in 36% of the isolates, primarily from skin and soft tissue infections, while fusC (SCC-borne fusidic acid resistance) was identified in 13% of the isolates. Conclusions: The findings highlight the ongoing evolution of MRSA in the UAE, with the persistence and emergence of diverse and rare clonal complexes, driving the need for continuous genomic surveillance.
Enterobacter hormaechei has emerged as a significant pathogen within healthcare settings due to its ability to develop multidrug resistance (MDR) and survive in hospital environments. This study presents a genome-based analysis of carbapenem-resistant Enterobacter hormaechei isolates from two major hospitals in the United Arab Emirates. Eight isolates were subjected to whole-genome sequencing (WGS), revealing extensive resistance profiles including the blaNDM-1, blaOXA-48, and blaVIM-4 genes. Notably, one isolate belonging to ST171 harbored dual carbapenemase genes, while five isolates exhibited colistin resistance without mcr genes. The presence of the type VI secretion system (T6SS), various adhesins, and virulence genes contributes to the virulence and competitive advantage of the pathogen. Additionally, our isolates (87.5%) possessed ampC β-lactamase genes, predominantly blaACT genes. The genomic context of blaNDM-1, surrounded by other resistance genes and mobile genetic elements, highlights the role of horizontal gene transfer (HGT) in the spread of resistance. Our findings highlight the need for rigorous surveillance, strategic antibiotic stewardship, and hospital-based WGS to manage and mitigate the spread of these highly resistant and virulent pathogens. Accurate identification and monitoring of Enterobacter cloacae complex (ECC) species and their resistance mechanisms are crucial for effective infection control and treatment strategies.
Fulminant meningococcemia classically presents with meningitis or septicemia accompanied by rash and meningeal signs. However, atypical presentations dominated by gastrointestinal symptoms may delay diagnosis and increase mortality. We report two cases of microbiologically confirmed meningococcemia in young, previously healthy adults presenting primarily with acute gastrointestinal symptoms and abdominal pain, without rash or meningeal signs. The first case involved a 31-year-old man presenting with acute abdomen, septic shock, and multiorgan dysfunction who survived following early microbiological diagnosis and prompt antimicrobial therapy. The second case involved a 22-year-old man presenting with vomiting and septic shock who rapidly deteriorated and succumbed despite early resuscitation. Blood cultures in both cases grew Neisseria meningitidis serogroup W135.
25 December 2025 in International Journal of Infectious Diseases
Brevibacterium casei, historically regarded as a harmless skin commensal, is increasingly recognized as an opportunistic pathogen in immunocompromised individuals. Catheter-Related Bloodstream Infections (CRBSIs) due to B. casei remain rare but are clinically significant, particularly among patients with multiple comorbidities and indwelling vascular devices. We report a CRBSI caused by B. casei in a 69-year-old male with ischemic heart disease, chronic obstructive pulmonary disease and acute kidney injury. The diagnosis was established through blood cultures from both a dialysis catheter and a peripheral vein. The patient showed clinical improvement following catheter removal and a combination of Piperacillin-Tazobactam with Levofloxacin.
Pandoraea species are multidrug-resistant (MDR) Gram-negative bacteria increasingly recognized as opportunistic pathogens beyond cystic fibrosis (CF). To our knowledge, we report the first documented case of Pandoraea apista bacteremia in the Middle East, occurring in a 41-year-old non-CF woman with postrevision ventriculoperitoneal (VP) shunt hydrocephalus, metastatic cervical carcinoma, and renal failure. Presenting with fever, hematuria, and obstructive uropathy, the patient developed catheter-related bloodstream infection (CRBSI) and urinary tract infection. P. apista was identified via MALDI-TOF MS (matrix-assisted laser desorption/ionization time-of-flight mass spectrometry) from blood and urine cultures, displaying resistance to ceftazidime and meropenem but susceptibility to ciprofloxacin, which led to clinical improvement. This case highlights the emerging threat of P. apista in immunocompromised, non-CF patients with indwelling devices, emphasizing the critical role of precise microbiological identification and susceptibilityguided therapy in managing such infections.